We Did It: Our Course on Antidepressant Tapering Is Now Part of U.S. Continuing Medical Education
And you can watch it too!
Good News! - "We Did It: Our Course on Antidepressant Tapering Is Now Part of U.S. Continuing Medical Education
And you can watch it too.
~ It's free!
- By Dr Anders Sørensen
June 2 2026
Ten years ago, if you had told me that American doctors would one day be able to earn continuing medical education credits for learning how to safely taper antidepressants based on our research here in Denmark 🇩🇰 , I probably wouldn’t have believed you.
Yet here we are.
I’m excited to share that our course - developed together with psychiatrist Georgia Ede - has now been approved for Continuing Medical Education (CME) in the United States. 🇺🇸
That means physicians can take the course as part of their official continuing education and receive CME credits for completing it.
For me, this represents a milestone: the growing recognition that withdrawal from antidepressants (and all psychiatric drugs, really) is a real clinical issue that deserves proper attention and education.
For decades, patients have been told that withdrawal symptoms are typically mild, short-lived, and resolved within a few weeks.
That they’re no biggie, really, and that tapering is no problem. Yet over the last several years, a growing body of research has painted a more complicated picture.
Many experience severe and prolonged withdrawal symptoms that can closely resemble relapse, creating confusion for both patients and clinicians.
The challenge is that most healthcare professionals have never received formal training in this area.
That gap between research and clinical practice is one of the reasons so many people struggle when trying to come off psychiatric medications. Simple as that.
The goal of this course is simple: to help close that gap.
We cover the principles of hyperbolic tapering, withdrawal symptoms, distinguishing withdrawal from relapse, psychological strategies to get through periods of withdrawal, and practical strategies for reducing medication safely and as comfortably as possible.
Most importantly, we try to translate research findings into something clinicians can actually use in everyday practice.
Another thing I’m particularly happy about is that the course is completely free.
The team behind the project - Metabolic Mind - made a deliberate decision that cost should not be a barrier to accessing this information. Anyone interested can take the course.
This Course Isn’t Just for Clinicians
Although the course was designed for healthcare professionals, patients, family members, and advocates are very welcome to take it as well.
In fact, many people who have struggled with antidepressant withdrawal tell me they wish they had access to this kind of information years earlier.
The topics are covered in a way that is accessible even if you don’t have a medical background.
So whether you’re a clinician, someone currently tapering, or simply trying to better understand these issues, I hope you’ll find it useful.
How You Can Help
If you are a healthcare professional, I encourage you to take a look.
If you are a patient, consider sharing it with your doctor, psychiatrist, nurse practitioner, therapist, or anyone involved in your care.
Many clinicians genuinely want to help their patients taper safely. Often, they simply haven’t had access to the latest evidence or practical training.
Education changes that.
One clinician learning about withdrawal can improve the care of hundreds of patients over the course of a career.
The course is available here:
https://www.mycme.com/courses/stopping-antidepressants-with-hyperbolic-tapering-10792
You're currently a free subscriber to Crossing Zero. For the full experience, upgrade your subscription."
----- Share to spread awareness and help save lives!
Dr Anders Sørensen is a Champion of Awareness
Stopping Antidepressants with Hyperbolic Tapering
CME | 2.00 Credits
Program DescriptionThe purpose of this CME activity is to educate practicing physicians and other healthcare professionals about how to safely discontinue long-term antidepressant use without triggering withdrawal relapse.
While clinical practice guidelines specify a recommended duration for pharmacological intervention, clinical guidelines have not updated their descriptions of the prevalence, severity, duration, and nature of antidepressant withdrawal symptoms for decades, despite a substantial increase in scientific research on the topic.
Intended Audience
The main target audiences are primary care and psychiatry physicians, nurse practitioners, and physician assistants.
Also, of important consideration are licensed mental health therapists, dietitians and other healthcare professional.
All levels of experience are welcome.Grant SupportThis activity is supported by an educational grant from Metabolic Mind which is a non-profit organization.
Choose the Right Place at the Right Time
Know When to Contact your Doctor, Urgent Care, or Emergency Services
Not Sure Where to Start?
Find Drug Warning Leaflets - Free Support - Safe Tips - Get Involved
Topic Links
Awareness and Recovery Starts Here
Connect with other survivors online
Using search feature is another option
Deliver by Certified Proof of Delivery
Results of the Cymbalta Class Action
Often hidden and censored by the media
Avoid starting psych drugs, or taper off
Your safety and well being, and success is top priority. We all have a right to know drug risks.
Find support from those who understand, and can help you online from home, free. Read about their journey, shared insight, and post to ask questions or request support. Share tips and your experiences to help others.
Find Support from those who understand, and can help you from home, free. Click title or photo to the Support page, for lists of the best support groups.
Your safety and well being, and success is top priority.
Read about their journey, and post for support, or ask questions, and share tips and your experiences to help others.





.png)























